Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all. See our community guidelines here: https://www.servier.us/community-guidelines To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us
View Top Employees from Servier PharmaceuticalsWebsite | https://www.servier.us/ |
Employees | 856 (692 on RocketReach) |
Founded | 2018 |
Address | 200 Pier Four Boulevard, Boston, Massachusetts 02210, US |
Technologies | |
Industry | Pharmaceutical Manufacturing |
Keywords | Pharmaceutical Solutions, Health Innovation, Patient Centered Care, Accessible Healthcare, Pharmaceutical Products, Pharmaceutical Research, Drug Development And Manufacturing, Healthcare Solution, Advanced Patient Care |
Looking for a particular Servier Pharmaceuticals employee's phone or email?
David Lee is the CEO of Servier Pharmaceuticals.
692 people are employed at Servier Pharmaceuticals.
Servier Pharmaceuticals is based in Boston, Massachusetts.